Načítá se...
Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors
[Image: see text] Antibacterials with a novel mechanism of action offer a great opportunity to combat widespread antimicrobial resistance. Bacterial DNA Gyrase is a clinically validated target. Through physiochemical property optimization of a pyrazolopyridone hit, a novel class of GyrB inhibitors w...
Uloženo v:
Vydáno v: | ACS Med Chem Lett |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
American Chemical
Society
2015
|
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601062/ https://ncbi.nlm.nih.gov/pubmed/26487916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00266 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|